Sean P. Duffy - Jun 5, 2025 Form 3 Insider Report for Omada Health, Inc. (OMDA)

Role
Chief Executive Officer, Director
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy
Stock symbol
OMDA
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
3
Date filed
6/5/2025, 04:36 PM
Next filing
Sep 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duffy Sean P. Chief Executive Officer, Director C/O OMADA HEALTH, INC., 500 SANSOME STREET, SUITE 200, SAN FRANCISCO /s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy 2025-06-05 0002069522

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMDA Common Stock 861K Jun 5, 2025 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 271K $2.55 Direct F1, F3
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 7.33K $3.48 Direct F1, F3
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 181K $5.82 Direct F1, F3
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 133K $8.28 Direct F1, F3
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 7.33K $9.18 Direct F1, F3
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 533K $9.18 Direct F1, F4
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 150K $4.74 Direct F1, F5
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 83.3K $8.01 Direct F1, F6
holding OMDA Stock Option (Right to Buy) Jun 5, 2025 Common Stock 133K $7.68 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
F2 Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
F3 The option is fully vested and exercisable.
F4 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F6 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F7 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney